A condition affecting eight thousand people costs about the same to research as one affecting eight million. Same trial design, decade, and regulators. What changes is who you sell the answer to. So for eight thousand people, the answer mostly doesn't get looked for. They aren't a market. They could still be a fund.
This content is for informational and educational purposes only. It may include third-party insights, sponsored content, or promotional material for which the creator may receive compensation. Nothing in this feed constitutes investment advice or a guarantee of returns. You are solely responsible for your own investment decisions. Always conduct your own research and exercise caution before trading. We do not guarantee the accuracy of third-party information and are not liable for any losses incurred. Past performance is not indicative of future results. Please refer to our Community Terms and Risk Disclosure Statement for details.
Post your reply